Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 3/20 | 0.77 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.77 |
| ▸ | BCR | P11274 | 3/20 | 0.77 |
| ▸ | MAOB | P27338 | 2/20 | 0.62 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | CYP4B1 | P13584 | 1/20 | 0.61 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.61 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.61 |
| ▸ | CYP2A7 | P20853 | 1/20 | 0.61 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.61 |
| ▸ | CYP2F1 | P24903 | 1/20 | 0.61 |
| ▸ | CYP2C18 | P33260 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL792197 | 1.00 | ABL1 (0.77) | ABL1ABCB1BCRMAOBCYP1A1 | |
| SCHEMBL1181204 | 0.98 | ABL1 (0.81) | ABL1ABCB1BCRMAOBCYP1A1 | |
| SCHEMBL1180343 | 0.95 | ABL1 (0.69) | ABL1ABCB1BCRMAOBCYP1A1 | |
| SCHEMBL9414212 | 0.91 | ABL1 (0.66) | ABL1ABCB1BCRMAOBCYP1A1 | |
| SCHEMBL13247865 | 0.91 | ABL1 (0.64) | ABL1ABCB1BCRMAOBCYP1A1 | |
| SCHEMBL1180429 | 0.91 | ABL1 (0.83) | ABL1ABCB1BCRCYP1A1CYP1A2 | |
| SCHEMBL196765 | 0.91 | CYP3A4 (0.73) | ABL1ABCB1BCRMAOBCYP1A1 | |
| SCHEMBL29489425 | 0.91 | CYP3A4 (0.73) | ABL1ABCB1BCRMAOBCYP1A1 | |
| SCHEMBL29740761 | 0.88 | CYP1A1 (0.64) | ABL1ABCB1BCRMAOBCYP1A1 | |
| SCHEMBL458391 | 0.88 | CYP1A1 (0.64) | ABL1ABCB1BCRMAOBCYP1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110046147-A1 | 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-RELATED DISEASES | UNIVERSITAT DES SAARLANDES (DE) | 2011-02-24 | — | — | US | disclosed |
| US-20110046147-A1 | 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-RELATED DISEASES | UNIVERSITAT DES SAARLANDES (DE) | 2011-02-24 | — | — | US | disclosed |
| EP-2190421-A2 | 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-DEPENDENT DISEASES | Universität des Saarlandes (DE) | 2010-06-02 | — | — | EP | disclosed |
| WO-2009027346-A2 | 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-DEPENDENT DISEASES | Universität des Saarlandes (DE) | 2009-03-05 | — | — | WO | disclosed |
| WO-2009027346-A2 | 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-DEPENDENT DISEASES | Universität des Saarlandes (DE) | 2009-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046147-A1 | 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-RELATED DISEASES | HSD17B1, HSD17B11, HSD17B2 | ABL1 3119/4885ABCB1 1384/4885BCR 2990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.